

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.10244700 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.73508965 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.68504780 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.55890628 |
| 5 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.17878547 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.17708923 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.15901687 |
| 8 | vocalization behavior (GO:0071625) | 5.11753345 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.04537945 |
| 10 | glutamate secretion (GO:0014047) | 5.04472492 |
| 11 | neuronal action potential propagation (GO:0019227) | 4.83685994 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81223195 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.76993089 |
| 14 | protein localization to synapse (GO:0035418) | 4.75243382 |
| 15 | glycosphingolipid catabolic process (GO:0046479) | 4.66589146 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 4.55610047 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.50539899 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.48134449 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.47332769 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.34377910 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.31646684 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.27590643 |
| 23 | exploration behavior (GO:0035640) | 4.27503576 |
| 24 | adenosine receptor signaling pathway (GO:0001973) | 4.18325767 |
| 25 | long-term memory (GO:0007616) | 4.14382888 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.13220173 |
| 27 | glycolipid catabolic process (GO:0019377) | 4.13068758 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.12933924 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.08639963 |
| 30 | regulation of mononuclear cell migration (GO:0071675) | 4.07775024 |
| 31 | positive regulation of membrane potential (GO:0045838) | 4.07322351 |
| 32 | positive regulation of mast cell degranulation (GO:0043306) | 4.04799018 |
| 33 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.04799018 |
| 34 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.02907163 |
| 35 | ceramide catabolic process (GO:0046514) | 3.95769987 |
| 36 | transmission of nerve impulse (GO:0019226) | 3.91828922 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85016454 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.83583015 |
| 39 | neurotransmitter secretion (GO:0007269) | 3.82174248 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80445991 |
| 41 | regulation of synaptic plasticity (GO:0048167) | 3.75803003 |
| 42 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.74553371 |
| 43 | neuron recognition (GO:0008038) | 3.70441665 |
| 44 | oligosaccharide catabolic process (GO:0009313) | 3.70421665 |
| 45 | neuronal ion channel clustering (GO:0045161) | 3.70031697 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.64392682 |
| 47 | layer formation in cerebral cortex (GO:0021819) | 3.62101478 |
| 48 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.59539606 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.59193437 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.54571253 |
| 51 | regulation of dendritic spine development (GO:0060998) | 3.54207921 |
| 52 | dendritic spine organization (GO:0097061) | 3.52299921 |
| 53 | N-acetylneuraminate metabolic process (GO:0006054) | 3.50223799 |
| 54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.48438916 |
| 55 | L-amino acid import (GO:0043092) | 3.47426179 |
| 56 | positive regulation of leukocyte degranulation (GO:0043302) | 3.47040488 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46718017 |
| 58 | amino sugar catabolic process (GO:0046348) | 3.45893619 |
| 59 | synaptic vesicle endocytosis (GO:0048488) | 3.45505106 |
| 60 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.45192035 |
| 61 | regulation of vesicle fusion (GO:0031338) | 3.44695227 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.42652372 |
| 63 | regulation of glutamate secretion (GO:0014048) | 3.42480331 |
| 64 | presynaptic membrane organization (GO:0097090) | 3.42471225 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.40821329 |
| 66 | membrane lipid catabolic process (GO:0046466) | 3.36299434 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.36139214 |
| 68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.35854009 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 3.34967900 |
| 70 | positive regulation of dendritic spine development (GO:0060999) | 3.33979535 |
| 71 | negative regulation of amino acid transport (GO:0051956) | 3.32047303 |
| 72 | axonal fasciculation (GO:0007413) | 3.30500843 |
| 73 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.27791222 |
| 74 | regulation of neurotransmitter secretion (GO:0046928) | 3.25909385 |
| 75 | proline transport (GO:0015824) | 3.25444164 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 3.25047336 |
| 77 | regulation of mast cell degranulation (GO:0043304) | 3.24749092 |
| 78 | regulation of macrophage chemotaxis (GO:0010758) | 3.23850731 |
| 79 | neurotransmitter transport (GO:0006836) | 3.21970372 |
| 80 | regulation of leukocyte degranulation (GO:0043300) | 3.21232896 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 3.20937136 |
| 82 | sphingolipid catabolic process (GO:0030149) | 3.19590671 |
| 83 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.19437701 |
| 84 | neuromuscular process controlling balance (GO:0050885) | 3.15988826 |
| 85 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.14454316 |
| 86 | ganglioside metabolic process (GO:0001573) | 3.14330080 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 3.13884190 |
| 88 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12788722 |
| 89 | membrane depolarization (GO:0051899) | 3.11928182 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 3.11810032 |
| 91 | positive regulation of heat generation (GO:0031652) | 3.11588614 |
| 92 | activation of protein kinase A activity (GO:0034199) | 3.10129235 |
| 93 | chemosensory behavior (GO:0007635) | 3.09358209 |
| 94 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.08270053 |
| 95 | mating behavior (GO:0007617) | 3.07532493 |
| 96 | glycerophospholipid catabolic process (GO:0046475) | 3.07327431 |
| 97 | amino acid import (GO:0043090) | 3.06012763 |
| 98 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.05306798 |
| 99 | neutrophil activation involved in immune response (GO:0002283) | 3.04307639 |
| 100 | learning (GO:0007612) | 3.04131541 |
| 101 | response to acidic pH (GO:0010447) | 3.02446114 |
| 102 | vesicle transport along microtubule (GO:0047496) | 3.00188544 |
| 103 | behavioral fear response (GO:0001662) | 2.99287169 |
| 104 | behavioral defense response (GO:0002209) | 2.99287169 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.99075440 |
| 106 | long term synaptic depression (GO:0060292) | 2.96875625 |
| 107 | adult walking behavior (GO:0007628) | 2.96778903 |
| 108 | positive regulation of synapse maturation (GO:0090129) | 2.96366568 |
| 109 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95918136 |
| 110 | positive regulation of neurotransmitter transport (GO:0051590) | 2.94950335 |
| 111 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.94614923 |
| 112 | postsynaptic membrane organization (GO:0001941) | 2.94578334 |
| 113 | phagosome maturation (GO:0090382) | 2.94281919 |
| 114 | alanine transport (GO:0032328) | 2.94208586 |
| 115 | sodium ion export (GO:0071436) | 2.94116921 |
| 116 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93668484 |
| 117 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92888284 |
| 118 | regulation of synaptic transmission (GO:0050804) | 2.92645590 |
| 119 | response to peptidoglycan (GO:0032494) | 2.92474732 |
| 120 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.92266409 |
| 121 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.91602642 |
| 122 | regulation of neurotransmitter levels (GO:0001505) | 2.91162492 |
| 123 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.89614629 |
| 124 | regulation of neurotransmitter transport (GO:0051588) | 2.89182595 |
| 125 | regulation of ARF protein signal transduction (GO:0032012) | 2.89044337 |
| 126 | membrane hyperpolarization (GO:0060081) | 2.88679744 |
| 127 | dendrite morphogenesis (GO:0048813) | 2.86790184 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.86203249 |
| 129 | central nervous system myelination (GO:0022010) | 2.85873470 |
| 130 | axon ensheathment in central nervous system (GO:0032291) | 2.85873470 |
| 131 | synaptic transmission (GO:0007268) | 2.85097911 |
| 132 | cellular response to arsenic-containing substance (GO:0071243) | 2.84943926 |
| 133 | positive regulation of synaptic transmission (GO:0050806) | 2.84463317 |
| 134 | cerebellar granule cell differentiation (GO:0021707) | 2.82944688 |
| 135 | glycine transport (GO:0015816) | 2.82755802 |
| 136 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.81710085 |
| 137 | mannose metabolic process (GO:0006013) | 2.81135239 |
| 138 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.81035756 |
| 139 | fear response (GO:0042596) | 2.79526840 |
| 140 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.78905028 |
| 141 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.78460362 |
| 142 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.78460362 |
| 143 | glycosphingolipid biosynthetic process (GO:0006688) | 2.77878012 |
| 144 | transferrin transport (GO:0033572) | 2.77526042 |
| 145 | detection of calcium ion (GO:0005513) | 2.77240548 |
| 146 | positive regulation of regulated secretory pathway (GO:1903307) | 2.75380623 |
| 147 | sphingosine metabolic process (GO:0006670) | 2.73472130 |
| 148 | monocyte chemotaxis (GO:0002548) | 2.69671801 |
| 149 | lysosome organization (GO:0007040) | 2.68128625 |
| 150 | lytic vacuole organization (GO:0080171) | 2.68128625 |
| 151 | regulation of mast cell activation (GO:0033003) | 2.66821054 |
| 152 | glycosylceramide metabolic process (GO:0006677) | 2.66253938 |
| 153 | germinal center formation (GO:0002467) | 2.61637349 |
| 154 | positive regulation of Rap GTPase activity (GO:0032854) | 2.58948747 |
| 155 | regulation of cholesterol storage (GO:0010885) | 2.58673713 |
| 156 | barbed-end actin filament capping (GO:0051016) | 2.58289305 |
| 157 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.57379993 |
| 158 | purinergic receptor signaling pathway (GO:0035587) | 2.56789903 |
| 159 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.54308638 |
| 160 | cellular response to ATP (GO:0071318) | 2.53917638 |
| 161 | negative regulation of mast cell activation (GO:0033004) | 2.51067641 |
| 162 | diol metabolic process (GO:0034311) | 2.50572103 |
| 163 | regulation of monocyte chemotaxis (GO:0090025) | 2.48371314 |
| 164 | response to thyroid hormone (GO:0097066) | 2.47950780 |
| 165 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47282750 |
| 166 | ferric iron transport (GO:0015682) | 2.46891459 |
| 167 | trivalent inorganic cation transport (GO:0072512) | 2.46891459 |
| 168 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46766276 |
| 169 | adhesion of symbiont to host (GO:0044406) | 2.43803928 |
| 170 | adhesion of symbiont to host cell (GO:0044650) | 2.42366274 |
| 171 | virion attachment to host cell (GO:0019062) | 2.42366274 |
| 172 | response to auditory stimulus (GO:0010996) | 2.39926096 |
| 173 | regulation of fever generation (GO:0031620) | 2.38695466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.91507238 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.46427737 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.30499326 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.27299352 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21736217 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13543289 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11928822 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.98459356 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.84810629 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.84810629 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.76811298 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74679938 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.73739682 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.70818188 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.69494375 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.68638044 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.65694693 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.64529558 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.63358722 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61734824 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.60413362 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.52901499 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52273226 |
| 24 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.47093089 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.41335401 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41184644 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37303976 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.35266728 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.33813181 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.30301726 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.26265418 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20613190 |
| 33 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19417069 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18983944 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07242047 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03220661 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01196062 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89273401 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85316910 |
| 40 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84244259 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81854135 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77567743 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.77375362 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72005743 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69329341 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68824678 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67623052 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63741385 |
| 49 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60667861 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58778498 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54233188 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53892659 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53610328 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51043317 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50063115 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49664683 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48215077 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46537828 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46523852 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45369810 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45101420 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44024808 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43888070 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.43669101 |
| 65 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43505391 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43340817 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43250777 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39760707 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39670791 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38299462 |
| 71 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35400248 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34577132 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.34200461 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33591207 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32469670 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.32340852 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31462361 |
| 78 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30747136 |
| 79 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.29894174 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29584879 |
| 81 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28686288 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28093911 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26103767 |
| 84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25322483 |
| 85 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24273366 |
| 86 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22501877 |
| 87 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22337226 |
| 88 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22109646 |
| 89 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21044659 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20970462 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19814902 |
| 92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19461319 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18655547 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16579381 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16433583 |
| 96 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16316900 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16122794 |
| 98 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15282181 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14285138 |
| 100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14110592 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13646387 |
| 102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13328211 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13086588 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12555754 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12548705 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12308450 |
| 107 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11977992 |
| 108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11953441 |
| 109 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11859924 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11040546 |
| 111 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11001374 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09858325 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08983135 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07990710 |
| 115 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07385607 |
| 116 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07297963 |
| 117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06691779 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06316506 |
| 119 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05730281 |
| 120 | AR_19668381_ChIP-Seq_PC3_Human | 1.05548723 |
| 121 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05469521 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04397979 |
| 123 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03926983 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03501406 |
| 125 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03181010 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03117503 |
| 127 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03008058 |
| 128 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02452485 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01689006 |
| 130 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01136494 |
| 131 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00726415 |
| 132 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99774442 |
| 133 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99312107 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98990933 |
| 135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98065994 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97989648 |
| 137 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97617472 |
| 138 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.96994216 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96730288 |
| 140 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.96482125 |
| 141 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96246591 |
| 142 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95467455 |
| 143 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94946123 |
| 144 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94786566 |
| 145 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94759021 |
| 146 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94723991 |
| 147 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94627158 |
| 148 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94401464 |
| 149 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93858298 |
| 150 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93797542 |
| 151 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.93780085 |
| 152 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.93037614 |
| 153 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92226368 |
| 154 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91149156 |
| 155 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89874678 |
| 156 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89833695 |
| 157 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89468463 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89351680 |
| 159 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89100832 |
| 160 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87562295 |
| 161 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87483220 |
| 162 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86553029 |
| 163 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85211662 |
| 164 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84073998 |
| 165 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.83438767 |
| 166 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83438767 |
| 167 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82724397 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81566976 |
| 169 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80105159 |
| 170 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.79729032 |
| 171 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79166830 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.78691314 |
| 173 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78158746 |
| 174 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.77224937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.28482149 |
| 2 | MP0003880_abnormal_central_pattern | 5.56722485 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.40482101 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.27051263 |
| 5 | MP0004270_analgesia | 3.98584330 |
| 6 | MP0009745_abnormal_behavioral_response | 3.64727608 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.36742091 |
| 8 | MP0002064_seizures | 3.35546122 |
| 9 | MP0003172_abnormal_lysosome_physiology | 3.32993898 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.88127240 |
| 11 | MP0002272_abnormal_nervous_system | 2.81101546 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.79321027 |
| 13 | MP0009046_muscle_twitch | 2.74879253 |
| 14 | MP0001486_abnormal_startle_reflex | 2.71383590 |
| 15 | MP0009840_abnormal_foam_cell | 2.60229304 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.49117488 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.45259796 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.43111065 |
| 19 | MP0002822_catalepsy | 2.40550483 |
| 20 | MP0006082_CNS_inflammation | 2.39829197 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.39206801 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.34270797 |
| 23 | MP0002736_abnormal_nociception_after | 2.31693091 |
| 24 | MP0003329_amyloid_beta_deposits | 2.30950738 |
| 25 | MP0005671_abnormal_response_to | 2.30642876 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 2.08630834 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 2.04300928 |
| 28 | MP0005387_immune_system_phenotype | 1.90004515 |
| 29 | MP0001790_abnormal_immune_system | 1.90004515 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.88019511 |
| 31 | MP0003436_decreased_susceptibility_to | 1.86029062 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.84860178 |
| 33 | MP0000685_abnormal_immune_system | 1.83005097 |
| 34 | MP0008569_lethality_at_weaning | 1.81245708 |
| 35 | MP0001970_abnormal_pain_threshold | 1.81225990 |
| 36 | MP0000920_abnormal_myelination | 1.80214885 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.80103928 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.75834728 |
| 39 | MP0002419_abnormal_innate_immunity | 1.75347364 |
| 40 | MP0003879_abnormal_hair_cell | 1.74031412 |
| 41 | MP0000343_altered_response_to | 1.67792408 |
| 42 | MP0004924_abnormal_behavior | 1.67329927 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.67329927 |
| 44 | MP0002254_reproductive_system_inflammat | 1.65344141 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.62766554 |
| 46 | MP0000778_abnormal_nervous_system | 1.62465612 |
| 47 | MP0004885_abnormal_endolymph | 1.59067932 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.58526332 |
| 49 | MP0000955_abnormal_spinal_cord | 1.57393711 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.55690738 |
| 51 | MP0003787_abnormal_imprinting | 1.55414118 |
| 52 | MP0005025_abnormal_response_to | 1.55061219 |
| 53 | MP0004142_abnormal_muscle_tone | 1.53940433 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.52815632 |
| 55 | MP0002723_abnormal_immune_serum | 1.50330061 |
| 56 | MP0002184_abnormal_innervation | 1.49398233 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.48693700 |
| 58 | MP0009785_altered_susceptibility_to | 1.48658903 |
| 59 | MP0001905_abnormal_dopamine_level | 1.45397017 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.41010186 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.40310609 |
| 62 | MP0001800_abnormal_humoral_immune | 1.40232566 |
| 63 | MP0004947_skin_inflammation | 1.38733800 |
| 64 | MP0001529_abnormal_vocalization | 1.38616020 |
| 65 | MP0003690_abnormal_glial_cell | 1.34968980 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.34334634 |
| 67 | MP0005166_decreased_susceptibility_to | 1.33136495 |
| 68 | MP0004858_abnormal_nervous_system | 1.28861138 |
| 69 | MP0004742_abnormal_vestibular_system | 1.27734156 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.27441192 |
| 71 | MP0003045_fibrosis | 1.27326080 |
| 72 | MP0003633_abnormal_nervous_system | 1.25952063 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.25370372 |
| 74 | MP0001819_abnormal_immune_cell | 1.24237078 |
| 75 | MP0001835_abnormal_antigen_presentation | 1.23231887 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.21716490 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.20739253 |
| 78 | MP0003631_nervous_system_phenotype | 1.19402928 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.18148945 |
| 80 | MP0004510_myositis | 1.16854523 |
| 81 | MP0002090_abnormal_vision | 1.14272291 |
| 82 | MP0000604_amyloidosis | 1.13600798 |
| 83 | MP0002229_neurodegeneration | 1.12397513 |
| 84 | MP0002152_abnormal_brain_morphology | 1.11050741 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.10746470 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.10473890 |
| 87 | MP0009764_decreased_sensitivity_to | 1.09515979 |
| 88 | MP0008874_decreased_physiological_sensi | 1.08848923 |
| 89 | MP0001533_abnormal_skeleton_physiology | 1.08459789 |
| 90 | MP0003632_abnormal_nervous_system | 1.06778120 |
| 91 | MP0006276_abnormal_autonomic_nervous | 1.05354184 |
| 92 | MP0002405_respiratory_system_inflammati | 1.04621516 |
| 93 | MP0003075_altered_response_to | 1.04145273 |
| 94 | MP0008961_abnormal_basal_metabolism | 1.03412630 |
| 95 | MP0001986_abnormal_taste_sensitivity | 1.02574178 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 1.01888180 |
| 97 | MP0002796_impaired_skin_barrier | 1.00093612 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 0.99873449 |
| 99 | MP0003634_abnormal_glial_cell | 0.99839528 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.98791247 |
| 101 | MP0001984_abnormal_olfaction | 0.96544261 |
| 102 | MP0009333_abnormal_splenocyte_physiolog | 0.94949274 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.94037810 |
| 104 | MP0001188_hyperpigmentation | 0.94012708 |
| 105 | MP0005410_abnormal_fertilization | 0.93268441 |
| 106 | MP0008469_abnormal_protein_level | 0.92827478 |
| 107 | MP0009278_abnormal_bone_marrow | 0.92781729 |
| 108 | MP0008872_abnormal_physiological_respon | 0.91909602 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.91301439 |
| 110 | MP0005646_abnormal_pituitary_gland | 0.90766660 |
| 111 | MP0005171_absent_coat_pigmentation | 0.86491553 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.85302204 |
| 113 | MP0005409_darkened_coat_color | 0.84993477 |
| 114 | MP0005551_abnormal_eye_electrophysiolog | 0.84757273 |
| 115 | MP0000716_abnormal_immune_system | 0.84549946 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.82894977 |
| 117 | MP0001177_atelectasis | 0.82152287 |
| 118 | MP0004043_abnormal_pH_regulation | 0.81929515 |
| 119 | MP0003448_altered_tumor_morphology | 0.81499384 |
| 120 | MP0000751_myopathy | 0.81230458 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.80429701 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.80305178 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.78822575 |
| 124 | MP0003195_calcinosis | 0.77892649 |
| 125 | MP0003303_peritoneal_inflammation | 0.77109668 |
| 126 | MP0004381_abnormal_hair_follicle | 0.75111977 |
| 127 | MP0003122_maternal_imprinting | 0.74839124 |
| 128 | MP0002752_abnormal_somatic_nervous | 0.74775802 |
| 129 | MP0002098_abnormal_vibrissa_morphology | 0.71518094 |
| 130 | MP0001853_heart_inflammation | 0.70931140 |
| 131 | MP0005310_abnormal_salivary_gland | 0.65561119 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.62946685 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.62616917 |
| 134 | MP0005535_abnormal_body_temperature | 0.62381783 |
| 135 | MP0004085_abnormal_heartbeat | 0.60730380 |
| 136 | MP0004484_altered_response_of | 0.59356291 |
| 137 | MP0001664_abnormal_digestion | 0.59080688 |
| 138 | MP0000747_muscle_weakness | 0.58075585 |
| 139 | MP0000013_abnormal_adipose_tissue | 0.56088232 |
| 140 | MP0010678_abnormal_skin_adnexa | 0.55444583 |
| 141 | MP0000003_abnormal_adipose_tissue | 0.54455401 |
| 142 | MP0003861_abnormal_nervous_system | 0.53330716 |
| 143 | MP0001943_abnormal_respiration | 0.53296097 |
| 144 | MP0010769_abnormal_survival | 0.53184659 |
| 145 | MP0010768_mortality/aging | 0.49960763 |
| 146 | MP0003956_abnormal_body_size | 0.48909640 |
| 147 | MP0010770_preweaning_lethality | 0.48693337 |
| 148 | MP0002082_postnatal_lethality | 0.48693337 |
| 149 | MP0002837_dystrophic_cardiac_calcinosis | 0.48010166 |
| 150 | MP0000026_abnormal_inner_ear | 0.46812301 |
| 151 | MP0000631_abnormal_neuroendocrine_gland | 0.45882905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.54683908 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 7.48287777 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.48287777 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.48287777 |
| 5 | Myokymia (HP:0002411) | 7.13095441 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.91264049 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.82214437 |
| 8 | Focal seizures (HP:0007359) | 5.75951875 |
| 9 | Scanning speech (HP:0002168) | 5.30243125 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.09096629 |
| 11 | Atonic seizures (HP:0010819) | 5.02680340 |
| 12 | Disinhibition (HP:0000734) | 4.98737499 |
| 13 | Epileptic encephalopathy (HP:0200134) | 4.76382001 |
| 14 | Visual hallucinations (HP:0002367) | 4.72722109 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.66271573 |
| 16 | Axonal loss (HP:0003447) | 4.17343842 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 4.16599986 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 4.09783682 |
| 19 | Dysmetria (HP:0001310) | 4.05030846 |
| 20 | Absence seizures (HP:0002121) | 4.04527379 |
| 21 | Febrile seizures (HP:0002373) | 4.00981797 |
| 22 | Loss of speech (HP:0002371) | 3.89374896 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.88885710 |
| 24 | Apathy (HP:0000741) | 3.83385718 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 3.79666485 |
| 26 | Dialeptic seizures (HP:0011146) | 3.79446790 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.71672860 |
| 28 | Diminished motivation (HP:0000745) | 3.67432788 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.67005497 |
| 30 | Agnosia (HP:0010524) | 3.63741877 |
| 31 | Postural instability (HP:0002172) | 3.62606967 |
| 32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.59720231 |
| 33 | Inappropriate behavior (HP:0000719) | 3.51239529 |
| 34 | Generalized tonic-clonic seizures (HP:0002069) | 3.48520005 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.48284036 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.48284036 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.48284036 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 3.46995932 |
| 39 | Broad-based gait (HP:0002136) | 3.41830844 |
| 40 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.41288216 |
| 41 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.41010773 |
| 42 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.41010773 |
| 43 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.40732882 |
| 44 | Spastic gait (HP:0002064) | 3.37479351 |
| 45 | Ankle clonus (HP:0011448) | 3.37310815 |
| 46 | Dysdiadochokinesis (HP:0002075) | 3.26607256 |
| 47 | Abnormality of the corticospinal tract (HP:0002492) | 3.22989608 |
| 48 | Mucopolysacchariduria (HP:0008155) | 3.21341849 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.21341849 |
| 50 | Action tremor (HP:0002345) | 3.15958126 |
| 51 | Hyperventilation (HP:0002883) | 3.08452875 |
| 52 | Intention tremor (HP:0002080) | 3.07894949 |
| 53 | Global brain atrophy (HP:0002283) | 3.07700540 |
| 54 | Amblyopia (HP:0000646) | 2.97943797 |
| 55 | Truncal ataxia (HP:0002078) | 2.95492336 |
| 56 | Poor eye contact (HP:0000817) | 2.93410206 |
| 57 | Depression (HP:0000716) | 2.89847119 |
| 58 | Urinary urgency (HP:0000012) | 2.85944978 |
| 59 | Personality changes (HP:0000751) | 2.83746242 |
| 60 | Anxiety (HP:0000739) | 2.81519284 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.78145768 |
| 62 | Nuclear cataract (HP:0100018) | 2.73501942 |
| 63 | Dementia (HP:0000726) | 2.73168978 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.69867350 |
| 65 | Genetic anticipation (HP:0003743) | 2.69523089 |
| 66 | Impaired social interactions (HP:0000735) | 2.68850534 |
| 67 | Abnormal social behavior (HP:0012433) | 2.68850534 |
| 68 | Sensory axonal neuropathy (HP:0003390) | 2.67751643 |
| 69 | Glomerulonephritis (HP:0000099) | 2.66529543 |
| 70 | Upper motor neuron abnormality (HP:0002127) | 2.65519998 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.65340485 |
| 72 | Retinal atrophy (HP:0001105) | 2.63475721 |
| 73 | Insidious onset (HP:0003587) | 2.55924562 |
| 74 | Termporal pattern (HP:0011008) | 2.55924562 |
| 75 | Fetal akinesia sequence (HP:0001989) | 2.55638651 |
| 76 | Impaired smooth pursuit (HP:0007772) | 2.55013828 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.49642965 |
| 78 | Abnormal eating behavior (HP:0100738) | 2.49482666 |
| 79 | Hemiparesis (HP:0001269) | 2.43328185 |
| 80 | Impaired vibratory sensation (HP:0002495) | 2.43029321 |
| 81 | Hemiplegia (HP:0002301) | 2.40484659 |
| 82 | Generalized myoclonic seizures (HP:0002123) | 2.40228590 |
| 83 | Insomnia (HP:0100785) | 2.39692787 |
| 84 | Delusions (HP:0000746) | 2.38349270 |
| 85 | Peripheral hypomyelination (HP:0007182) | 2.37542201 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.37532730 |
| 87 | Diplopia (HP:0000651) | 2.37532730 |
| 88 | Absent speech (HP:0001344) | 2.36996230 |
| 89 | Papilledema (HP:0001085) | 2.36608099 |
| 90 | Bradykinesia (HP:0002067) | 2.33068588 |
| 91 | Akinesia (HP:0002304) | 2.32880910 |
| 92 | Eczematoid dermatitis (HP:0000976) | 2.32763339 |
| 93 | Lower limb muscle weakness (HP:0007340) | 2.31346776 |
| 94 | Memory impairment (HP:0002354) | 2.30458047 |
| 95 | Stereotypic behavior (HP:0000733) | 2.27659033 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.26506732 |
| 97 | Excessive salivation (HP:0003781) | 2.23184200 |
| 98 | Drooling (HP:0002307) | 2.23184200 |
| 99 | Agitation (HP:0000713) | 2.16597045 |
| 100 | Mutism (HP:0002300) | 2.16309220 |
| 101 | Hematochezia (HP:0002573) | 2.15643604 |
| 102 | Status epilepticus (HP:0002133) | 2.14198120 |
| 103 | Epileptiform EEG discharges (HP:0011182) | 2.14120074 |
| 104 | Urinary incontinence (HP:0000020) | 2.13048304 |
| 105 | Neoplasm of the adrenal cortex (HP:0100641) | 2.12313917 |
| 106 | Cerebral aneurysm (HP:0004944) | 2.10951549 |
| 107 | Progressive neurologic deterioration (HP:0002344) | 2.10042231 |
| 108 | Mediastinal lymphadenopathy (HP:0100721) | 2.09886271 |
| 109 | Abnormality of the lower motor neuron (HP:0002366) | 2.08134977 |
| 110 | Torticollis (HP:0000473) | 2.07790056 |
| 111 | Retinal dysplasia (HP:0007973) | 2.07720601 |
| 112 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.07109538 |
| 113 | Dysmetric saccades (HP:0000641) | 2.06649548 |
| 114 | Thickened helices (HP:0000391) | 2.05092774 |
| 115 | Abnormality of the periventricular white matter (HP:0002518) | 2.05090780 |
| 116 | Lower limb amyotrophy (HP:0007210) | 2.04163223 |
| 117 | Focal dystonia (HP:0004373) | 2.03140417 |
| 118 | Onion bulb formation (HP:0003383) | 2.02047546 |
| 119 | Cardiomegaly (HP:0001640) | 2.01860114 |
| 120 | Progressive inability to walk (HP:0002505) | 2.01386696 |
| 121 | Abnormality of saccadic eye movements (HP:0000570) | 2.00505983 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.99778953 |
| 123 | Type II lissencephaly (HP:0007260) | 1.99754621 |
| 124 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99656410 |
| 125 | Absent/shortened dynein arms (HP:0200106) | 1.99656410 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99300589 |
| 127 | Megalencephaly (HP:0001355) | 1.96368069 |
| 128 | Polyphagia (HP:0002591) | 1.94114503 |
| 129 | Psychosis (HP:0000709) | 1.94028750 |
| 130 | Annular pancreas (HP:0001734) | 1.93942197 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 1.93094351 |
| 132 | Clonus (HP:0002169) | 1.93025386 |
| 133 | Rigidity (HP:0002063) | 1.89986808 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.89486919 |
| 135 | Abnormality of salivation (HP:0100755) | 1.89389190 |
| 136 | Hypsarrhythmia (HP:0002521) | 1.89152738 |
| 137 | Progressive visual loss (HP:0000529) | 1.86957162 |
| 138 | Stomach cancer (HP:0012126) | 1.86627126 |
| 139 | Spastic tetraparesis (HP:0001285) | 1.86469567 |
| 140 | Complement deficiency (HP:0004431) | 1.86249811 |
| 141 | J-shaped sella turcica (HP:0002680) | 1.84915910 |
| 142 | Basal ganglia calcification (HP:0002135) | 1.84860224 |
| 143 | Incomplete penetrance (HP:0003829) | 1.84523313 |
| 144 | Peripheral demyelination (HP:0011096) | 1.84519213 |
| 145 | Metaphyseal irregularity (HP:0003025) | 1.84325418 |
| 146 | Clumsiness (HP:0002312) | 1.82425562 |
| 147 | Widely spaced teeth (HP:0000687) | 1.81910028 |
| 148 | Blue irides (HP:0000635) | 1.81475803 |
| 149 | Thoracic kyphosis (HP:0002942) | 1.80512810 |
| 150 | Pointed chin (HP:0000307) | 1.79853673 |
| 151 | Ankyloglossia (HP:0010296) | 1.78917739 |
| 152 | Macroglossia (HP:0000158) | 1.77092775 |
| 153 | Specific learning disability (HP:0001328) | 1.76135251 |
| 154 | Rapidly progressive (HP:0003678) | 1.74739451 |
| 155 | Cerebral hypomyelination (HP:0006808) | 1.74335005 |
| 156 | Purpura (HP:0000979) | 1.73555638 |
| 157 | Ventricular fibrillation (HP:0001663) | 1.70487560 |
| 158 | Myoclonus (HP:0001336) | 1.69177023 |
| 159 | Stomatitis (HP:0010280) | 1.67486950 |
| 160 | Pathologic fracture (HP:0002756) | 1.62938685 |
| 161 | Dysphonia (HP:0001618) | 1.58540520 |
| 162 | Increased IgE level (HP:0003212) | 1.58500815 |
| 163 | Abnormality of chloride homeostasis (HP:0011422) | 1.54396067 |
| 164 | Limb ataxia (HP:0002070) | 1.54025051 |
| 165 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.53500391 |
| 166 | Increased CSF protein (HP:0002922) | 1.53306941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.14274982 |
| 2 | NTRK3 | 4.10814721 |
| 3 | MAP3K9 | 3.87608578 |
| 4 | NME2 | 2.79497730 |
| 5 | MAP3K11 | 2.71506983 |
| 6 | RIPK4 | 2.67972734 |
| 7 | IRAK3 | 2.51393311 |
| 8 | BLK | 2.36495117 |
| 9 | PAK6 | 2.34733483 |
| 10 | DAPK2 | 2.34048671 |
| 11 | KSR2 | 2.33923545 |
| 12 | MINK1 | 2.19440220 |
| 13 | MAP3K13 | 2.19096686 |
| 14 | MAP3K4 | 2.16095362 |
| 15 | PRPF4B | 2.14923433 |
| 16 | CDK19 | 2.11820997 |
| 17 | ACVR1B | 2.04198733 |
| 18 | TNIK | 2.04183577 |
| 19 | CAMK1D | 2.03637524 |
| 20 | ARAF | 1.90689278 |
| 21 | OXSR1 | 1.85671176 |
| 22 | PRKCH | 1.78442426 |
| 23 | MAP3K14 | 1.78292339 |
| 24 | NTRK1 | 1.71013915 |
| 25 | GRK7 | 1.69240402 |
| 26 | PNCK | 1.68831900 |
| 27 | MARK1 | 1.67553572 |
| 28 | MAP2K7 | 1.64796833 |
| 29 | PRKD3 | 1.64041541 |
| 30 | STK39 | 1.62165637 |
| 31 | CDK5 | 1.55268051 |
| 32 | RIPK1 | 1.52692305 |
| 33 | FES | 1.50094147 |
| 34 | KSR1 | 1.46027888 |
| 35 | TYRO3 | 1.45697136 |
| 36 | TGFBR2 | 1.45382757 |
| 37 | PLK2 | 1.43875753 |
| 38 | TBK1 | 1.43446778 |
| 39 | NTRK2 | 1.43113184 |
| 40 | CAMKK1 | 1.42835977 |
| 41 | ERN1 | 1.42791626 |
| 42 | IKBKB | 1.41179928 |
| 43 | MAP4K1 | 1.38860874 |
| 44 | TESK1 | 1.34044418 |
| 45 | ADRBK2 | 1.33372153 |
| 46 | MAP3K12 | 1.32774230 |
| 47 | PIM2 | 1.31249622 |
| 48 | DDR2 | 1.29621962 |
| 49 | TAOK2 | 1.29273592 |
| 50 | DAPK1 | 1.27604624 |
| 51 | FGR | 1.26804423 |
| 52 | PTK2B | 1.25794424 |
| 53 | TESK2 | 1.24604239 |
| 54 | CDC42BPA | 1.24269846 |
| 55 | SIK2 | 1.22986182 |
| 56 | MAP2K4 | 1.21199473 |
| 57 | LIMK1 | 1.20731505 |
| 58 | TGFBR1 | 1.19745757 |
| 59 | ZAK | 1.17825216 |
| 60 | UHMK1 | 1.17346283 |
| 61 | CAMK2B | 1.17142991 |
| 62 | RAF1 | 1.14386954 |
| 63 | GRK5 | 1.12881113 |
| 64 | MAP3K2 | 1.11532055 |
| 65 | STK38 | 1.09034282 |
| 66 | MAP2K6 | 1.08177702 |
| 67 | CSF1R | 1.07812260 |
| 68 | SYK | 1.06360526 |
| 69 | CAMK1 | 1.05003643 |
| 70 | CAMK2A | 1.04921539 |
| 71 | CASK | 1.03944630 |
| 72 | PRKCG | 1.03639916 |
| 73 | BMPR2 | 1.01138582 |
| 74 | ALK | 0.99913635 |
| 75 | NEK6 | 0.97539143 |
| 76 | MAP3K7 | 0.96590449 |
| 77 | ABL2 | 0.96341479 |
| 78 | PAK3 | 0.94726903 |
| 79 | CDK15 | 0.93913392 |
| 80 | CDK18 | 0.92416642 |
| 81 | CDK14 | 0.91912516 |
| 82 | STK11 | 0.90720483 |
| 83 | NME1 | 0.90541851 |
| 84 | ICK | 0.89326351 |
| 85 | TNK2 | 0.88744215 |
| 86 | MARK2 | 0.88049300 |
| 87 | MAP3K3 | 0.87327285 |
| 88 | PDK1 | 0.83114053 |
| 89 | CDK11A | 0.82163716 |
| 90 | TYK2 | 0.80923535 |
| 91 | PDPK1 | 0.80128921 |
| 92 | CAMK4 | 0.80123104 |
| 93 | TXK | 0.79524895 |
| 94 | TAOK1 | 0.78872053 |
| 95 | WNK4 | 0.77200599 |
| 96 | BRAF | 0.76748182 |
| 97 | SIK3 | 0.71378548 |
| 98 | SIK1 | 0.70395333 |
| 99 | CAMK2D | 0.70366856 |
| 100 | PKN1 | 0.69567778 |
| 101 | WNK1 | 0.69076547 |
| 102 | TLK1 | 0.67438585 |
| 103 | MAP3K1 | 0.67289109 |
| 104 | DYRK1A | 0.67057721 |
| 105 | SGK1 | 0.66710900 |
| 106 | CLK1 | 0.65875778 |
| 107 | CSNK1G2 | 0.65565922 |
| 108 | SGK494 | 0.65348853 |
| 109 | SGK223 | 0.65348853 |
| 110 | MAPK12 | 0.63267066 |
| 111 | ROCK2 | 0.63256791 |
| 112 | GRK6 | 0.61347443 |
| 113 | MAPK13 | 0.60643566 |
| 114 | BCR | 0.60617579 |
| 115 | CAMK2G | 0.59965709 |
| 116 | PRKCQ | 0.59763912 |
| 117 | FYN | 0.59210204 |
| 118 | RET | 0.56209374 |
| 119 | MATK | 0.55697759 |
| 120 | CAMKK2 | 0.54971688 |
| 121 | DAPK3 | 0.54274985 |
| 122 | LYN | 0.53451210 |
| 123 | PRKD2 | 0.52142029 |
| 124 | CSK | 0.51721108 |
| 125 | DMPK | 0.49883181 |
| 126 | CHUK | 0.48864500 |
| 127 | IRAK2 | 0.44794566 |
| 128 | ZAP70 | 0.44243186 |
| 129 | IKBKE | 0.43717098 |
| 130 | JAK1 | 0.43622614 |
| 131 | CSNK1A1L | 0.43358740 |
| 132 | MAP2K2 | 0.42814325 |
| 133 | RPS6KA3 | 0.41271926 |
| 134 | IRAK4 | 0.39379723 |
| 135 | PRKCE | 0.39325196 |
| 136 | CAMK1G | 0.38947332 |
| 137 | JAK2 | 0.38923959 |
| 138 | CSNK1E | 0.38619305 |
| 139 | FER | 0.37532991 |
| 140 | MAPK10 | 0.37190369 |
| 141 | PINK1 | 0.35442532 |
| 142 | MOS | 0.33535984 |
| 143 | CSNK1G3 | 0.33459852 |
| 144 | PRKCZ | 0.32547227 |
| 145 | PRKCA | 0.30739184 |
| 146 | FGFR2 | 0.29399434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.96826682 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76618694 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.75866243 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10092322 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.82877307 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.79395596 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75140964 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.73587521 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72997186 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.59850112 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57334938 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.50161342 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.37377310 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.26737865 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12191331 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03740028 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03675806 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00054227 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.98717385 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95866343 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.89980664 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88259574 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.88254132 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.87849857 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.82084303 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81299222 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72785550 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69092094 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68736321 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67593620 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.66833300 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.63001430 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.59597962 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55240171 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.54757609 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53891955 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49025955 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48243928 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44175942 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41583603 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.39128022 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.36660530 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36433303 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32365428 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.30816312 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30039444 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29409480 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26924775 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.26694314 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.24546711 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.24478182 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 1.23545166 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21815514 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16738334 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14804674 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13260527 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13174195 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12652216 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10076745 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08356337 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.07799067 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06941424 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04851081 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03143337 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01696476 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01412386 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00837237 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00410228 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98040607 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96136988 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93049195 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90862368 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90457214 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89758782 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83651845 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.82068627 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80762610 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78661020 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78594646 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77490577 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76977337 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73138046 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72610998 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72519849 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72442968 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70459419 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69104398 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68416482 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68264933 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66309242 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64897546 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.64724168 |
| 93 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.64138417 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | 0.63462156 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60391352 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.60269808 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60102249 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57855098 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56852334 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56154429 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56076259 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55943137 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53539457 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52821883 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52074256 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50977778 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.49555433 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49291811 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49167957 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49005221 |
| 111 | Malaria_Homo sapiens_hsa05144 | 0.46528669 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46431469 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46194489 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.45455586 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45199481 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42779488 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42521511 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42401179 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42388513 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42302689 |
| 121 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42285321 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42104455 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.39642632 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.39130774 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38856931 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.38665947 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38619492 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38401180 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36521394 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36085854 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34901483 |
| 132 | Bile secretion_Homo sapiens_hsa04976 | 0.33516014 |
| 133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32998833 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32613225 |
| 135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30229966 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29741348 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.25449647 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25398106 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.24451349 |

